MedPath

Oral pharyngeal anesthesia for Upper Gastrointestinal Endoscopy

Phase 1
Conditions
Topical local anesthesia for upper gastrointestinal endoscopy
MedDRA version: 21.1Level: LLTClassification code 10024760Term: Local anestheticSystem Organ Class: 100000004865
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2020-005177-27-DK
Lead Sponsor
Bispebjerg Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
248
Inclusion Criteria

Patients referred to and found fit for upper GI endoscopy in an out patient setting
Between 18 and 75 years old
Speaks and understands Danish
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 200
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 48

Exclusion Criteria

Patients admitted for upper GI endoscopy in an in-patient setting
Patients with dementia and/or other cognitive dysfunction disorders
Patients primarly complaining of dysphagia
Patients allergic to lidocaine
Patients with suspected retention
Patients who will undergo upper GI endoscopy with nurse-assisted propofol sedation
Patients who will undergo upper GI endoscopy with assistance of anesthesia-personnel

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To determine if placebo is non-inferior to viscous lidocaine for upper gastrointestinal endoscopy;Secondary Objective: Not applicable;Primary end point(s): Ease of intubation [Time Frame: Immediately after the procedure]<br>The endocopist will rate the difficulty of intubating the esophagus on a numeric rating scale NRS 0-10;Timepoint(s) of evaluation of this end point: Immediately after the procedure
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath